Quarterly report pursuant to Section 13 or 15(d)

Schedule of Earnings (Loss) Per Share (Details)

v3.21.2
Schedule of Earnings (Loss) Per Share (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Net income (loss) attributable to common shareholders     $ (3,997,550) $ 2,703,767
Convertible notes     (4,921,950)
Net loss for diluted earnings per share     $ (3,997,550) $ (2,218,183)
Weighted-average number of common shares outstanding during the period 58,487,227 9,833,073 50,084,150 6,368,543
Dilutive effect of convertible notes payable     8,696,619
Common stock and common stock equivalents used for diluted earnings per share 58,487,227 9,833,073 50,084,150 15,065,162